Yseop Finalist in 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials

We are thrilled to share that Yseop has been named a finalist in the 2023 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials. We are incredibly proud of our team for their hard work and dedication, which has led to this achievement.

As a finalist in the “Best Use of Artificial Intelligence in Clinical Trials” category, our Augmented Analyst platform was recognized as an AI solution with the potential to revolutionize the clinical trial process. This recognition highlights our commitment to leveraging cutting-edge AI technologies to drive innovation in the pharmaceutical industry.

By automating essential components of specialist medical reports, such as Clinical Study Reports (CSRs) and Patient Narratives, our platform streamlines the report writing process and saves valuable time for healthcare professionals. With Yseop’s advanced AI solutions, you can expect accurate and comprehensive reports that meet the highest industry standards.

We are honored to be recognized among other exciting startups looking to change the game in pharmaceutical services. As we move towards 2030, the global artificial intelligence in healthcare market is predicted to reach $208.2 billion, and we can anticipate AI healthcare trends evolving even further, including intelligent report automation, acceleration of drug development and vaccines, and augmented workforce.

Being named a finalist in such a competitive category is a testament to our team’s hard work and dedication. We remain committed to driving innovation in the pharmaceutical industry and leveraging the power of AI to transform the clinical trial process and look forward to the ceremony on April 27, 2023 to announce the winner.